Search

Search Constraints

You searched for: Author/Creator Olichney, John M.

Search Results

1. ACT‐AD: Fosgonimeton in mild‐to‐moderate Alzheimer's disease – first results of a randomized, placebo‐controlled, 26‐week Phase 2 proof‐of‐concept trial. (20th December 2022)

2. Association of vascular brain injury, neurodegeneration, amyloid, and cognitive trajectory. (10th November 2020)

5. Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting. (29th January 2019)

6. Multisite study of the relationships between antemortem [11C]PIB‐PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology. Issue 2 (19th October 2018)

7. O3‐04‐03: MRI MEASURES OF NEURODEGENERATION AND VASCULAR INJURY, BUT NOT AMYLOID STATUS, PREDICT COGNITIVE DECLINE IN NORMAL INDIVIDUALS FOLLOWED FOR 7 YEARS ON AVERAGE. (1st July 2019)

8. P3‐317: VITAMIN D INSUFFICIENCY PREDICTS INCIDENT COGNITIVE IMPAIRMENT IN AN ELDERLY MULTIETHNIC ADC COHORT. (1st July 2019)

9. Phenotypes of hypofrontality in older female fragile X premutation carriers. Issue 2 (24th September 2013)